Cell-based approaches towards treating age-related macular degeneration

Cell Tissue Bank. 2020 Sep;21(3):339-347. doi: 10.1007/s10561-020-09826-3. Epub 2020 Mar 10.

Abstract

Age-related macular degeneration as one of the most common causes of worldwide vision loss needs a proper approach for treatment. Therein, cell therapy and regenerative medicine can hold a great promise to be an effective approach. Accordingly, some preclinical and clinical studies were conducted to search around the therapeutic influence of stem cells in Age-related macular degeneration models and subjects. Hereupon, the purpose of the current review is to discuss the mechanisms of age-related macular degeneration, appropriate animal models along with suitable dosage and route of stem cell administration for its treatment.

Keywords: Age-related macular degeneration; Animal models; Cell therapy; Clinical trials.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell- and Tissue-Based Therapy*
  • Clinical Trials as Topic
  • Disease Models, Animal
  • Drug Approval
  • Humans
  • Macular Degeneration / therapy*
  • United States
  • United States Food and Drug Administration